Judgment of the EU Court of Justice in AstraZeneca v Commission
On 6 December 2012, the EU Court of Justice dismissed AstraZeneca’s appeal of the General Court’s judgment in AstraZeneca v Commission. The Court of Justice affirmed the reasoning and holdings of the General Court and rejected all of AstraZeneca’s arguments, including its challenge to the General Court’s analysis of the definition of the relevant markets and the findings that AstraZeneca’s IP and regulatory strategies related to its product Losec constituted an abuse of a dominant position in violation of Article 102 TFEU. This judgment, from the EU’s highest court, solidifies the concept of an abuse of IP and regulatory procedures, and thus will come as a disappointment to many life science companies.
Click on the link above to download this Covington & Burling briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from The Lawyer
Briefings from Covington & Burling
On 8 May China’s Supreme People’s Court issued its Rules on the Application of Laws for Adjudicating Civil Disputes Arising From Monopolistic Conduct.
Following a nine-month consultation process, the UK government has announced proposals for far-reaching changes to the mechanisms for seeking redress in antitrust actions.
Analysis from The Lawyer
Footie and telecoms dominate our regular round-up of recent M&A activity, as the threat of rising interest rates kick-started activity among organisations.